Marwan Ghosn

Summary

Country: Lebanon

Publications

  1. doi request reprint A phase II randomized study comparing navelbine and capecitabine (Navcap) followed either by Navcap or by weekly docetaxel in the first-line treatment of HER-2/neu negative metastatic breast cancer
    M Ghosn
    Hematology and Medical Oncology Department, Hotel Dieu de France University Hospital, Alfred Naccache BLVD, PO Box 166830 Beirut, Lebanon
    Med Oncol 28:S142-51. 2011
  2. doi request reprint Sequential FOLFOX-6 and gemcitabine for locally advanced and/or metastatic pancreatic cancer
    M Ghosn
    Department of Oncology Hematology, Hotel Dieu de France University Hospital, Achrafieh, Blvd Alfred Naccache, P O Box 166830, Beirut, Lebanon
    Med Oncol 29:2831-7. 2012
  3. ncbi request reprint Sequential vinorelbine-capecitabine followed by docetaxel in advanced breast cancer: long-term results of a pilot phase II trial
    Marwan Ghosn
    Department of Oncology, Hematology, Hotel Dieu de France University Hospital, Achrafieh, Blvd Alfred Naccache, P O Box 166830, Beirut, Lebanon
    Cancer Chemother Pharmacol 62:11-8. 2008
  4. doi request reprint Experience with palliative care in patients with advanced cancer at a tertiary care hospital in a developing country
    Marwan Ghosn
    Hotel Dieu de France University Hospital, Achrafieh, Beirut, Lebanon
    Support Care Cancer 19:573-5. 2011
  5. pmc Triple-negative breast cancer in Lebanon: a case series
    Marwan Ghosn
    Saint Joseph University School of Medicine, Beirut, Lebanon
    Oncologist 16:1552-6. 2011
  6. ncbi request reprint FOLFOX-6 combination as the first-line treatment of locally advanced and/or metastatic pancreatic cancer
    Marwan Ghosn
    Hotel Dieu de France University Hospital, Beirut, Lebanon
    Am J Clin Oncol 30:15-20. 2007
  7. ncbi request reprint Phase II trial of capecitabine and vinorelbine as first-line chemotherapy for metastatic breast cancer patients
    Marwan Ghosn
    Department of Oncology Hematology, Hotel Dieu de France University Hospital, Achrafieh, Blvd Alfred Naccache, P O Box 166830, Beirut, Lebanon, France
    Anticancer Res 26:2451-6. 2006
  8. ncbi request reprint Current strategies in the treatment of metastatic hormone-refractory prostate cancer
    Marwan Ghosn
    Hematology Oncology Department, Hotel Dieu de France University Hospital, Beirut, Lebanon
    Tunis Med 83:74. 2005
  9. ncbi request reprint Outcome of cancer patients admitted to the intensive care unit (ICU)
    Marwan Ghosn
    Department of Hematology Oncology, Hotel Dieu de France Hospital, Beirut, Lebanon
    J Med Liban 50:132-6. 2002

Detail Information

Publications9

  1. doi request reprint A phase II randomized study comparing navelbine and capecitabine (Navcap) followed either by Navcap or by weekly docetaxel in the first-line treatment of HER-2/neu negative metastatic breast cancer
    M Ghosn
    Hematology and Medical Oncology Department, Hotel Dieu de France University Hospital, Alfred Naccache BLVD, PO Box 166830 Beirut, Lebanon
    Med Oncol 28:S142-51. 2011
    ..2%), and grade 2 alopecia (12%). Conclusion: Both Navcap and Navcap followed by Docetaxel regimens were tolerated with manageable toxicity, offering consistent activities in terms of response rate for metastatic breast cancer patients...
  2. doi request reprint Sequential FOLFOX-6 and gemcitabine for locally advanced and/or metastatic pancreatic cancer
    M Ghosn
    Department of Oncology Hematology, Hotel Dieu de France University Hospital, Achrafieh, Blvd Alfred Naccache, P O Box 166830, Beirut, Lebanon
    Med Oncol 29:2831-7. 2012
    ..In APC, FOLFOX-6 regimen followed by gemcitabine achieved an interesting RR within a tolerable level of toxicity. This regimen seems to warrant further investigation to confirm its efficacy...
  3. ncbi request reprint Sequential vinorelbine-capecitabine followed by docetaxel in advanced breast cancer: long-term results of a pilot phase II trial
    Marwan Ghosn
    Department of Oncology, Hematology, Hotel Dieu de France University Hospital, Achrafieh, Blvd Alfred Naccache, P O Box 166830, Beirut, Lebanon
    Cancer Chemother Pharmacol 62:11-8. 2008
    ..To evaluate the response rate of the combination of capecitabine (C) and vinorelbine (V) followed by Docetaxel (D) in the 1st line treatment of advanced and metastatic breast cancer patients...
  4. doi request reprint Experience with palliative care in patients with advanced cancer at a tertiary care hospital in a developing country
    Marwan Ghosn
    Hotel Dieu de France University Hospital, Achrafieh, Beirut, Lebanon
    Support Care Cancer 19:573-5. 2011
    ..Revisiting the continuum of cancer care is called for to better identify the optimal timing of intervention and avoid end of life distress...
  5. pmc Triple-negative breast cancer in Lebanon: a case series
    Marwan Ghosn
    Saint Joseph University School of Medicine, Beirut, Lebanon
    Oncologist 16:1552-6. 2011
    ..To determine the incidence, characteristics, and survival outcomes of triple-negative breast cancer patients in a medical oncology practice in Lebanon...
  6. ncbi request reprint FOLFOX-6 combination as the first-line treatment of locally advanced and/or metastatic pancreatic cancer
    Marwan Ghosn
    Hotel Dieu de France University Hospital, Beirut, Lebanon
    Am J Clin Oncol 30:15-20. 2007
    ..This phase II trial was conducted to investigate the efficacy of oxaliplatin, 5-FU, and folinic acid (FOLFOX-6) in previously untreated APC patients...
  7. ncbi request reprint Phase II trial of capecitabine and vinorelbine as first-line chemotherapy for metastatic breast cancer patients
    Marwan Ghosn
    Department of Oncology Hematology, Hotel Dieu de France University Hospital, Achrafieh, Blvd Alfred Naccache, P O Box 166830, Beirut, Lebanon, France
    Anticancer Res 26:2451-6. 2006
    ..The aim of this multicenter phase II trial was to assess the combination of capecitabine and vinorelbine as first-line chemotherapy in patients with metastatic breast cancer (MBC)...
  8. ncbi request reprint Current strategies in the treatment of metastatic hormone-refractory prostate cancer
    Marwan Ghosn
    Hematology Oncology Department, Hotel Dieu de France University Hospital, Beirut, Lebanon
    Tunis Med 83:74. 2005
  9. ncbi request reprint Outcome of cancer patients admitted to the intensive care unit (ICU)
    Marwan Ghosn
    Department of Hematology Oncology, Hotel Dieu de France Hospital, Beirut, Lebanon
    J Med Liban 50:132-6. 2002
    ..The duration of stay in the ICU was the only factor affecting mortality. Age, disease type and MV did not influence the mortality rate in this population...